April 1st 2025
A recap of the FDA submissions and regulatory decisions in urology from March 2025.
Antidepressant reduces overall symptoms of IC
August 1st 2004San Francisco--The tricyclic antidepressant amitriptyline (Elavil) is a safe and effective treatment for interstitial cystitis with significant benefits for reducing overall symptoms along with pain and urgency, according to the results of a German study.
Survivors of prostate Ca are second largest group of cancer survivors
July 8th 2004Prostate cancer survivors are the second largest group of cancer survivors in the United States, following breast cancer survivors as the largest group, according to a report by the Centers for Disease Control and Prevention and the National Cancer Institute.
Antibiotic, alpha-blocker ineffective for CP/CPPS
July 1st 2004San Francisco--A commonly prescribed antibiotic and alpha-blocker appear to be ineffective in the treatment of men with moderate to severe chronic prostatitis/chronic pelvic pain syndrome of long duration. Results of a multicenter study found that both ciprofloxacin and tamsulosin-used primarily in the treatment of urinary tract infections and BPH, respectively-offered no significant benefit in the treatment of chronic prostatitis in patients who were heavily pretreated and had long-standing symptoms.
Fresh and frozen sperm equally efficacious for IVF
June 1st 2004San Francisco--It doesn't matter whether fresh or frozen spermis used for in vitro fertilization, as both have equivalent outcomes interms of fertilization rates, embryo quality, and the chance of having atleast one live birth event, according to a Mayo Clinic study.
How to diagnose and treat late-onset hypogonadism
February 1st 2004The last few years have witnessed an enormous interest in androgen replacement therapy for late-onset hypogonadism-also known as "androgen deficiency in the aging male." As urologists, we frequently deal with sexual dysfunction and are seen as experienced on issues of prostate health.
Varicocele repair offers potential to help infertile men
February 1st 2004Varicocele is a common clinical finding, present in approximately 15%of adult men. When the patient with a varicocele visits a urologist, itis often due to testicular discomfort or fertility-related concerns. Atthe 2003 meeting of the American Society for Reproductive Medicine, bothof these issues were addressed and are discussed in this issue of UrologyTimes.
Natural conception possible after varicocele repair
February 1st 2004San Antonio--Repair of clinically significant varicoceles may resultin nearly a 25% chance of natural conception, even in men who do not demonstratesignificant improvements in their postoperative seminal parameters, accordingto University of Iowa researchers.
Polishing the 'gold standard' in vasovasostomy
February 1st 2004San Antonio--Biomaterial wraps are a promising adjunct for vasovasostomy,according to results of an animal study that incorporated a biomaterialmatrix and a sealant into the conventional three-suture anastomosis. Researcherscalled this "polishing the gold standard" because of the highpatency rate of the standard procedure.
Cancer patients' semen is preserved late, used little
February 1st 2004San Antonio--A retrospective study of men with cancer who elected to cryopreservetheir sperm because of cancer therapy found that 20% of men had alreadyreceived one or more cycles of chemotherapy. The recognized toxic effectsof chemotherapy and radiation on sperm cells make this a questionable practice
95% of patients show no evidence of recurrence after prostate cryotherapy
December 11th 2003Among men undergoing cryotherapy for prostate cancer, 95% showed no biochemical evidence of cancer recurrence at a follow-up of 3.5 years in a small study presented at the Radiological Society of North America annual meeting.
Testosterone patch improves sexual desire in surgically menopausal women
September 25th 2003Treatment with a transdermal testosterone patch significantly increased sexual desire and sexual activity in women with hypoactive sexual desire disorder (HSDD) resulting from the surgical removal of both ovaries, a recent study showed.
Perspectives in Prostate Chemoprevention
September 1st 2003Chemoprevention is the use of natural or synthetic agents to avert the induction of, or to inhibit, delay, or suppress the progression of cancers or other diseases. Carcinogenesis is a process that occurs over a period of months to years and is under the influence of a range of genetic and environmental factors.
Managing prostatitis requires a multi-faceted approach
September 1st 2003Although antibiotics are commonly used to treat symptoms of chronic pelvicpain syndrome, this approach is beneficial in a relatively small subsetof patients, and urologists must consider alternative treatment modalities,including physical therapy. In this exclusive Urology Times interview, JeannettePotts, MD, discusses current research and her own views on the diagnosisand treatment of chronic prostatitis. Dr. Potts is a member of the staffat the Cleveland Clinic Glickman Urological Institute. The interview wasconducted by Philip M. Hanno, MD, of the department of urology, Universityof Pennsylvania, Philadelphia.
Endothelin receptor antagonist reduces markers of PCa
September 1st 2003Chicago-The selective endothelin receptor antagonist atrasentan significantly attenuates changes in biochemical markers of bone metabolism and disease progression in a group of patients with advanced hormone-refractory prostate cancer that had progressed on placebo, according to the results of a randomized clinical trial.
Decreased sperm density is linked to DNA damage
April 30th 2003Chicago-The etiology of male factor infertility remains one ofthe larger mysteries confronting urologists. A study from Baylor Collegeof Medicine suggests that the origins of the problem might lie with thetestes and may not involve either inflammation or oxidative radicals, assome have suggested.
Post-prostatectomy sildenafil improves erectile function recovery
April 29th 2003Chicago-Radical prostatectomy patients taking sildenafil postoperativelywere seven times more likely to report a return to spontaneous erectionsthan those taking placebo in a multi-institutional, double-blind study presentedhere yesterday.